Metraipolis › archive › dc_7d3678001087

Preclinical efficacy and safety of drug-loaded porous silicon nanoparticles for cancer treatment: a systematic review of in vitro and in vivo studies — Europe PMC PMID:42824511

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42824511
DOI
10.3389/fphar.2026.1969890
License (as archived)
solo-consultazione
Archived
2026-10-08T07:46:33.196Z
SHA-256 of the archived text
d60cdaa21a53794c2150f54d7b3ac3c100ea38af6ababadca7ee05abc14af293
Stable URL of this page
https://metraipolis.com/documento/dc_7d3678001087

How to cite

Preclinical efficacy and safety of drug-loaded porous silicon nanoparticles for cancer treatment: a systematic review of in vitro and in vivo studies — Europe PMC PMID:42824511 — Europe PMC (en), https://europepmc.org/article/MED/42824511 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7d3678001087 (Metraipolis archive dc_7d3678001087, sha256 d60cdaa21a53794c2150f54d7b3ac3c100ea38af6ababadca7ee05abc14af293)
BibTeX
@misc{dc7d3678001087,
  title = {Preclinical efficacy and safety of drug-loaded porous silicon nanoparticles for cancer treatment: a systematic review of in vitro and in vivo studies — Europe PMC PMID:42824511},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42824511},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7d3678001087; sha256 d60cdaa21a53794c2150f54d7b3ac3c100ea38af6ababadca7ee05abc14af293},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42824511. Agents can read the archived copy with the MCP tool read_document.